Literature DB >> 9198581

Measurement of the radioactive body burden in patients receiving iodine-131 treatment for carcinoma of the thyroid.

R Ravichandran, S S Supe, U Jayasree, S Devaru.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9198581     DOI： 10.1007/BF00881823

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


× No keyword cloud information.
  4 in total

1.  Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid.

Authors:  S F Barrington; A G Kettle; M J O'Doherty; C P Wells; E J Somer; A J Coakley
Journal:  Eur J Nucl Med       Date:  1996-02

2.  A comparison of methods for assessing patient body burden following 131I therapy for thyroid cancer.

Authors:  S R Thomas; H R Maxon; K M Fritz; J G Kereiakes; W D Connell
Journal:  Radiology       Date:  1980-12       Impact factor: 11.105

3.  Radiation safety considerations for post-iodine-131 hyperthyroid therapy.

Authors:  C M Culver; H J Dworkin
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

4.  Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery.

Authors:  A M Samuel; B Rajashekharrao
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057
  4 in total
  4 in total

1.  Estimation of effective half life of clearance of radioactive Iodine (I) in patients treated for hyperthyroidism and carcinoma thyroid.

Authors:  R Ravichandran; Jp Binukumar; Amal Al Saadi
Journal:  Indian J Nucl Med       Date:  2010-04

2.  Regarding Care Giving Family Members Stray Radiation Exposures from Discharged Patients after Administration of Large Dose Therapeutic Radioactive Iodine in Differentiated Carcinoma Thyroid.

Authors:  Ramamoorthy Ravichandran; Marwa Al Amri; Naima Al Balushi
Journal:  Indian J Nucl Med       Date:  2022-03-25

3.  Radioactive body burden measurements in (131)iodine therapy for differentiated thyroid cancer: effect of recombinant thyroid stimulating hormone in whole body (131)iodine clearance.

Authors:  Ramamoorthy Ravichandran; Amal Al Saadi; Naima Al Balushi
Journal:  World J Nucl Med       Date:  2014-01

4.  Radioactive (131)Iodine Body Burden and Blood Dose Estimates in Treatment for Differentiated Thyroid Cancer by External Probe Counting.

Authors:  Ramamoorthy Ravichandran; Naima Al Balushi
Journal:  World J Nucl Med       Date:  2016-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.